Wells Fargo’s Actuate Therapeutics, Inc. Common stock ACTU Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$78.2K	Buy	+12,796	New	+$78.2K	﹤0.01%	4923
2024 Q4	–	Sell	-3,392	Closed	-$25.3K	–	6646
2024 Q3	$25.3K	Buy	+3,392	New	+$25.3K	﹤0.01%	5169